Phase I dose-escalating study of ES-285 given as a three-hour intravenous infusion every three weeks in patients with advanced malignant solid tumors.

Details

Language :

English

ISSN :

01676997

Volume :

30

Issue :

6

Database :

Complementary Index

Journal :

Investigational New Drugs

Publication Type :

Academic Journal

Accession number :

82918077

Full Text :

https://doi.org/10.1007/s10637-011-9772-8